Coronavirus disease (COVID-19)

The European Medicines Agency (EMA) is contributing to global efforts to save lives during the COVID-19 pandemic by expediting the development and approval of safe and effective treatments and vaccines, supporting the continued availability of medicines in the European Union (EU), and providing reliable information to patients and healthcare professionals.

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.

On 30 January 2020, the World Health Organization (WHO) declared the outbreak a public health emergency of international concern. On 11 March 2020, WHO characterised COVID-19 as a pandemic.

There are currently no authorised vaccines or treatments in the EU to prevent or treat COVID-19. However, there are ongoing clinical trials evaluating potential treatments. 

The COVID-19 EMA pandemic Task Force is the main tool of EMA and the European medicines regulatory network for enabling EU Member States and the European Commission to take quick and coordinated regulatory action during the pandemic.

How useful was this page?

Add your rating
Average
28 ratings
4 ratings
1 rating
1 rating
4 ratings